GLUE / Monte Rosa Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Monte Rosa Therapeutics, Inc.
US ˙ NasdaqGS ˙ US61225M1027

Utestående aksjer 61,759,350 shares
Innsideraksjer107 616 234 shares
Totale insidere38
Insider Sentiment Score

Insider Sentiment Score finner selskapene som blir kjøpt av bedriftsinsidere.

Det er resultatet av en sofistikert, flerfaktor kvantitativ modell som identifiserer selskaper som har de høyeste nivåene av insiderakkumulasjon. Scoringsmodellen bruker en kombinasjon av netto antall insidere som kjøper de siste 90 dagene, det totale antallet kjøpte aksjer som en prosentandel av flyten, og det totale antallet aksjer eid av insidere. Tallet varierer fra 0 til 100, hvor høyere tall indikerer en høyere grad av akkumulasjon sammenlignet med jevnaldrende, og 50 er gjennomsnittet.

Oppdateringsfrekvens: Daglig

Se Insidernes Topp Picks, som gir en liste over selskaper med høyest akkumulasjon blant insidere.

Officer Sentiment Score

Officer Sentiment Score finner selskaper som kjøpes av bedriftsoffiserer.

Per definisjon er Corporate Officers Corporate Insiders, men i motsetning til noen av de andre innsiderne (10 % aksjonærer og styremedlemmer), jobber offiserer for selskapet på daglig basis, og de bruker sine egne penger når de handler . (10 % aksjonærer og styremedlemmer er ofte fondsforvaltere som forvalter andres penger.) Som sådan er innsidehandler utført av offiserer mye mer betydningsfulle og bør behandles på riktig måte.

Som Insider Sentiment Score er Officer Sentiment Score resultatet av en sofistikert, flerfaktor kvantitativ modell som identifiserer selskaper med de høyeste nivåene av akkumulasjon blant ledelsen.

Oppdateringsfrekvens: Daglig

Se Insidernes Topp Picks, som gir en liste over selskaper med høyest insider-sentiment.

Nøkkelindikatorer for insidere

Dette kortet viser hvordan selskapet rangerer langs ulike indikatorer for insidere. Percentile-rangeringen viser hvordan dette selskapet sammenligner seg med andre selskaper på USAs markeder. Høyere rangeringer indikerer bedre situasjoner.

For eksempel, er det generelt akseptert at insiderkjøp er en positiv indikator, så derfor ville selskaper som insiderkjøper mer, rangere høyere enn selskaper med mindre insiderkjøp (eller til og med insidersalg).

Netto antall insidere som kjøper (Rangering)

0 ( )

5615 out of 11308

Nettotall av innsidekjøp som kjøper er det totale antallet insidere som har kjøpt minus det totale antallet insidere som har solgt de siste 90 dagene. Den prosentvise rangeringen vises her (rangerer fra 0 til 100%).

Prosent av aksjeflyt kjøpt av insidere (rang)

0.000 %( )

5561 out of 11226

Prosenten av aksjeflyt kjøpt av innsidere er det totale antallet aksjer som er blitt kjøpt av innsidere minus det totale antallet aksjer solgt av innsidere de siste 90 dagene, delt på totalt antall utestående aksjer og multiplisert med 100.

Diagram over innsidehandel

Monte Rosa Therapeutics, Inc. insiderhandel vises i følgende diagram. Innsidere er ledere, direktører eller viktige investorer i et selskap. Generelt sett er det ulovlig for insidere å handle med aksjer i sine selskaper basert på materiell, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre any handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via en Form 4.

Insiderliste og lønnsomhetsmålinger

Denne tabellen viser listen over kjente insidere, og er automatisk generert fra arkiveringer offentliggjort av SEC. I tillegg til navn, siste tittel og direktør-, offiser- eller 10 % eier-betegnelse, gir vi de nyeste offentliggjorte beholdningene. I tillegg gir vi, når det er mulig, den historiske handelsytelsen for insidere. Den historiske handelsytelsen er et vektet gjennomsnitt av ytelsen til faktiske kjøpstransaksjoner som er gjort av insidere på det åpne markedet. For mer informasjon om hvordan dette blir beregnet, kan du se dette YouTube-webinaret.

See our leaderboard of most profitable insider traders.

Innsider Gjennomsnittlig fortjeneste (%) Aksjer
eid
Splitt
justert
Forest Baskett 10% Owner - [10%] 7 692 298 7 692 298
Ali Behbahani Director, 10% Owner - [D] [10%] 7 692 298 7 692 298
Bradley J PhD Bolzon Director, 10% Owner - [D] [10%] 2 097 938 2 097 938
Castle John C. Chief Data Scientist - [O] 17 310 17 310
Jennifer Champoux Chief Operating Officer - [O] 30 000 30 000
Carmen Chang 10% Owner - [10%] 7 692 298 7 692 298
Bihua Chen Director, 10% Owner - [D] [10%] 3 202 200 3 202 200
Cormorant Asset Management, LLC - 3 202 200 3 202 200
Cormorant Global Healthcare Master Fund, LP 10% Owner - [10%] 3 202 200 3 202 200
Cormorant Private Healthcare Fund II, LP 10% Owner - [10%] 3 202 200 3 202 200
Cormorant Private Healthcare Fund III LP 10% Owner - [10%] 3 202 200 3 202 200
Edmund Dunn Principal Accounting Officer - [O] 23 732 23 732
Innsider Gjennomsnittlig fortjeneste (%) Aksjer
eid
Splitt
justert
Florence Anthony A. Jr. 10% Owner - [10%] 7 692 298 7 692 298
Filip Janku Chief Medical Officer - [O] 45 189 45 189
Julian G Jones 73 300
Liza Landsman 10% Owner - [10%] 7 692 298 7 692 298
Leo Chandra P. Director - [D] 10 000 10 000
Joshua Makower 10% Owner - [10%] 7 692 298 7 692 298
Mohamad Makhzoumi 10% Owner - [10%] 7 692 298 7 692 298
Edward T Mathers 10% Owner - [10%] 7 692 298 7 692 298
Nea 17 Gp, Llc 10% Owner - [10%] 7 692 298 7 692 298
NEA Partners 17, L.P. 10% Owner - [10%] 7 692 298 7 692 298
New Enterprise Associates 17, L.P. 10% Owner - [10%] 7 692 298 7 692 298
Philip Nickson Chief Business & Legal Officer - [O] 36 000 36 000
Scott D Sandell 10% Owner - [10%] 7 692 298 7 692 298
Innsider Gjennomsnittlig fortjeneste (%) Aksjer
eid
Splitt
justert
Sonsini Peter W. 10% Owner - [10%] 7 692 298 7 692 298
Ajim Tamboli 111 700
Sharon Townson Chief Scientific Officer - [O] 36 000 36 000
Versant Vantage I GP, L.P. 10% Owner - [10%] 2 097 938 1 573 453
Versant Vantage I GP-GP, LLC 10% Owner - [10%] 2 097 938 1 573 453
Versant Vantage I, L.P. 10% Owner - [10%] 2 097 938 1 573 453
Versant Venture Capital VI, L.P. 10% Owner - [10%] 1 573 453 1 573 453
Versant Ventures VI GP, L.P. 10% Owner - [10%] 2 097 938 1 573 453
Versant Ventures VI GP-GP, LLC 10% Owner - [10%] 2 097 938 1 573 453
Paul Edward Walker 10% Owner - [10%] 7 692 298 7 692 298
Wallace Owen B. 117 450
Markus Warmuth President & CEO, Director - [D] [O] 544 538 544 538
Rick Yang 10% Owner - [10%] 7 692 298 7 692 298

Report errors via our new Insider Auditing Tool

Analyse av sporrekord for insiderkjøp - Kortsiktig lønnsomhetsanalyse

I denne seksjonen analyserer vi lønnsomheten til hver ikke-planlagte, åpne markeds innsidekjøp gjort i GLUE / Monte Rosa Therapeutics, Inc.. Denne analysen hjelper til med å forstå om insidere konsekvent genererer unormale avkastninger og er verdt å følge. Denne analysen gjelder for ett år etter hver handel, og resultatene er teoretiske .

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en automatisk handelsplan.

Handelsdato Innsider Rapporterte
aksjer
Rapportert
pris
Justert
aksjer
Justert
pris
Kostnadsgrunnlag Dager til
maks
Pris ved
maks
Maks
fortjeneste
Maks avkastning (%)
2025-03-24 Leo Chandra P. 10 000 5,8383 10 000 5,8383 58 383 121 5.9600 1 217 2,08
2021-06-28 Cormorant Asset Management, LLC 600 000 19,0000 600 000 19,0000 11 400 000
2021-06-28 Versant Venture Capital VI, L.P. 157 895 19,0000 157 895 19,0000 3 000 005
2021-06-28 Bolzon Bradley J PhD 157 895 19,0000 157 895 19,0000 3 000 005
2021-06-28 New Enterprise Associates 17, L.P. 1 050 000 19,0000 1 050 000 19,0000 19 950 000

Justert pris er prisen justert for splitt. Justerte aksjer er aksjer justert for splitt.

GLUE / Monte Rosa Therapeutics, Inc. Insider Trades
Analyse av sporrekord for insidesalg - Kortsiktig tapanalyse

I denne seksjonen analyserer vi kortsiktig tap til hver ikke-planlagte, åpne markeds innsidekjøp gjort i GLUE / Monte Rosa Therapeutics, Inc.. Et konsekvent mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder for ett år etter hver handel, og resultatene er teoretiske .

Følgende tabell viser de mest nylige åpne markedssalgene som ikke var en del av en automatisk trading plan.

Handelsdato Innsider Rapporterte
aksjer
Rapportert
pris
Justert
aksjer
Justert
pris
Kostnadsgrunnlag Dager til
min
Pris ved
min
Maks tap
ungått ($)
Maks tap
ungått (%)
2025-06-03 Dunn Edmund 2 062 4,4493 2 062 4,4493 9 174 69 4.1900 −534 −5,82
2024-10-29 Versant Venture Capital VI, L.P. 15 600 9,4098 15 600 9,4098 146 793
2024-10-29 Versant Venture Capital VI, L.P. 52 305 9,0815 52 305 9,0815 475 008
2024-10-28 Versant Venture Capital VI, L.P. 89 990 9,6593 89 990 9,6593 869 240
2024-09-20 Versant Venture Capital VI, L.P. 1 132 566 6,5296 1 132 566 6,5296 7 395 203
2024-09-13 Versant Venture Capital VI, L.P. 9 269 6,1603 9 269 6,1603 57 100
2024-09-12 Versant Venture Capital VI, L.P. 16 047 6,0017 16 047 6,0017 96 309
2024-09-11 Versant Venture Capital VI, L.P. 541 897 6,0000 541 897 6,0000 3 251 382
2024-07-05 Dunn Edmund 1 610 3,8301 1 610 3,8301 6 166
2024-06-03 Dunn Edmund 1 207 4,0396 1 207 4,0396 4 876

Justert pris er prisen justert for splitt. Justerte aksjer er aksjer justert for splitt.

GLUE / Monte Rosa Therapeutics, Inc. Insider Trades
Transaksjonshistorikk

Klikk på lenkeikonet for å se hele transaksjonshistorikken. Transaksjoner rapportert som en del av en automatisk handelsplan 10b5-1 vil ha en X i kolonnen merket 10b-5.

Fil
dato
Handels
dato
Skjema Innsider Ticker Verdipapirnavn Kode 10b5-1 Direkte Utøvelses
pris
Enhets
pris
Enheter
endret
Verdi
endret (1K)
Gjenværende
Opsjoner
Gjenværende
Aksjer
2025-06-04 2025-06-03 4 Dunn Edmund GLUE Common Stock S - Sale D 4,4493 −2 062 −9 23 732
2025-03-25 2025-03-24 4 Leo Chandra P. GLUE Common Stock P - Purchase D 5,8383 10 000 58 10 000
2025-01-06 2025-01-02 4 Warmuth Markus GLUE Common Stock A - Award D 128 000 544 538
2025-01-06 2025-01-02 4 Janku Filip GLUE Common Stock A - Award D 36 000 45 189
2025-01-06 2025-01-02 4 Townson Sharon GLUE Common Stock A - Award D 36 000 36 000
2025-01-06 2025-01-02 4 Champoux Jennifer GLUE Common Stock A - Award D 30 000 30 000
2025-01-06 2025-01-02 4 Dunn Edmund GLUE Common Stock A - Award D 11 850 25 794
2025-01-06 2025-01-02 4 Nickson Philip GLUE Common Stock A - Award D 36 000 36 000
2024-10-30 2024-10-29 4 Versant Venture Capital VI, L.P. GLUE Common Stock S - Sale I 9,4098 −15 600 −147 1 573 453
2024-10-30 2024-10-29 4 Versant Venture Capital VI, L.P. GLUE Common Stock S - Sale I 9,0815 −52 305 −475 1 589 053
2024-10-30 2024-10-28 4 Versant Venture Capital VI, L.P. GLUE Common Stock J - Other I −5 454 0
2024-10-30 2024-10-28 4 Versant Venture Capital VI, L.P. GLUE Common Stock J - Other I 5 454 5 454
2024-10-30 2024-10-28 4 Versant Venture Capital VI, L.P. GLUE Common Stock J - Other I −5 499 0
2024-10-30 2024-10-28 4 Versant Venture Capital VI, L.P. GLUE Common Stock J - Other I 5 499 5 499
2024-10-30 2024-10-28 4 Versant Venture Capital VI, L.P. GLUE Common Stock J - Other I −366 590 1 641 358
2024-10-30 2024-10-28 4 Versant Venture Capital VI, L.P. GLUE Common Stock J - Other I −17 595 0
2024-10-30 2024-10-28 4 Versant Venture Capital VI, L.P. GLUE Common Stock J - Other I 17 595 17 595
2024-10-30 2024-10-28 4 Versant Venture Capital VI, L.P. GLUE Common Stock J - Other I −20 397 0
2024-10-30 2024-10-28 4 Versant Venture Capital VI, L.P. GLUE Common Stock J - Other I 20 397 20 397
2024-10-30 2024-10-28 4 Versant Venture Capital VI, L.P. GLUE Common Stock J - Other D −1 019 867 4 079 469
2024-10-30 2024-10-28 4 Versant Venture Capital VI, L.P. GLUE Common Stock S - Sale I 9,6593 −89 990 −869 2 007 948
2024-09-24 2024-09-20 4 Versant Venture Capital VI, L.P. GLUE Common Stock S - Sale D 6,5296 −1 132 566 −7 395 5 099 336
2024-09-13 2024-09-13 4 Versant Venture Capital VI, L.P. GLUE Common Stock S - Sale D 6,1603 −9 269 −57 6 231 902
2024-09-13 2024-09-12 4 Versant Venture Capital VI, L.P. GLUE Common Stock S - Sale D 6,0017 −16 047 −96 6 241 171
2024-09-13 2024-09-11 4 Versant Venture Capital VI, L.P. GLUE Common Stock S - Sale D 6,0000 −541 897 −3 251 6 257 218
2024-07-09 2024-07-05 4 Dunn Edmund GLUE Common Stock S - Sale D 3,8301 −1 610 −6 13 944
2024-06-05 2024-06-03 4 Dunn Edmund GLUE Common Stock S - Sale D 4,0396 −1 207 −5 15 554
2023-08-18 3 Dunn Edmund GLUE Common Stock D 16 761
2022-03-02 2022-03-01 4 Jones Julian G GLUE Stock Option (Right to Buy) A - Award D 13,41 73 300 73 300
2022-03-02 2022-03-01 4 Janku Filip GLUE Stock Option (Right to Buy) A - Award D 13,41 86 500 86 500
2022-03-02 2022-03-01 4 Tamboli Ajim GLUE Stock Option (Right to Buy) A - Award D 13,41 111 700 111 700
2022-03-02 2022-03-01 4 Townson Sharon GLUE Stock Option (Right to Buy) A - Award D 13,41 70 000 70 000
2022-03-02 2022-03-01 4 Nickson Philip GLUE Stock Option (Right to Buy) A - Award D 13,41 70 600 70 600
2022-03-02 2022-03-01 4 Castle John C. GLUE Stock Option (Right to Buy) A - Award D 13,41 53 700 53 700
2022-03-02 2022-03-01 4 Wallace Owen B. GLUE Stock Option (Right to Buy) A - Award D 13,41 117 450 117 450
2022-03-02 2022-03-01 4 Warmuth Markus GLUE Stock Option (Right to Buy) A - Award D 13,41 315 600 315 600
2021-06-30 2021-06-28 4 Yang Rick See Note 2 GLUE Series C convertible preferred Stock C - Conversion I −2 361 912 0
2021-06-30 2021-06-28 4 Yang Rick See Note 2 GLUE Series B convertible preferred stock C - Conversion I −11 500 000 0
2021-06-30 2021-06-28 4 Yang Rick See Note 2 GLUE Series A-2 convertible preferred stock C - Conversion I −9 588 725 0
2021-06-30 2021-06-28 4 Yang Rick See Note 2 GLUE Common Stock P - Purchase I 19,0000 1 050 000 19 950 7 692 298
2021-06-30 2021-06-28 4 Yang Rick See Note 2 GLUE Common Stock C - Conversion I 669 002 6 642 298
2021-06-30 2021-06-28 4 Yang Rick See Note 2 GLUE Common Stock C - Conversion I 3 257 328 5 973 296
2021-06-30 2021-06-28 4 Yang Rick See Note 2 GLUE Common Stock C - Conversion I 2 715 968 2 715 968
2021-06-30 2021-06-28 4 Sonsini Peter W. See Note 2 GLUE Series C convertible preferred Stock C - Conversion I −2 361 912 0
2021-06-30 2021-06-28 4 Sonsini Peter W. See Note 2 GLUE Series B convertible preferred stock C - Conversion I −11 500 000 0
2021-06-30 2021-06-28 4 Sonsini Peter W. See Note 2 GLUE Series A-2 convertible preferred stock C - Conversion I −9 588 725 0
2021-06-30 2021-06-28 4 Sonsini Peter W. See Note 2 GLUE Common Stock P - Purchase I 19,0000 1 050 000 19 950 7 692 298
2021-06-30 2021-06-28 4 Sonsini Peter W. See Note 2 GLUE Common Stock C - Conversion I 669 002 6 642 298
2021-06-30 2021-06-28 4 Sonsini Peter W. See Note 2 GLUE Common Stock C - Conversion I 3 257 328 5 973 296
2021-06-30 2021-06-28 4 Sonsini Peter W. See Note 2 GLUE Common Stock C - Conversion I 2 715 968 2 715 968
2021-06-30 2021-06-28 4 Walker Paul Edward See Note 2 GLUE Series C convertible preferred Stock C - Conversion I −2 361 912 0
2021-06-30 2021-06-28 4 Walker Paul Edward See Note 2 GLUE Series B convertible preferred stock C - Conversion I −11 500 000 0
2021-06-30 2021-06-28 4 Walker Paul Edward See Note 2 GLUE Series A-2 convertible preferred stock C - Conversion I −9 588 725 0
2021-06-30 2021-06-28 4 Walker Paul Edward See Note 2 GLUE Common Stock P - Purchase I 19,0000 1 050 000 19 950 7 692 298
2021-06-30 2021-06-28 4 Walker Paul Edward See Note 2 GLUE Common Stock C - Conversion I 669 002 6 642 298
2021-06-30 2021-06-28 4 Walker Paul Edward See Note 2 GLUE Common Stock C - Conversion I 3 257 328 5 973 296
2021-06-30 2021-06-28 4 Walker Paul Edward See Note 2 GLUE Common Stock C - Conversion I 2 715 968 2 715 968
2021-06-30 2021-06-28 4 SANDELL SCOTT D See Note 2 GLUE Series C convertible preferred Stock C - Conversion I −2 361 912 0
2021-06-30 2021-06-28 4 SANDELL SCOTT D See Note 2 GLUE Series B convertible preferred stock C - Conversion I −11 500 000 0
2021-06-30 2021-06-28 4 SANDELL SCOTT D See Note 2 GLUE Series A-2 convertible preferred stock C - Conversion I −9 588 725 0
2021-06-30 2021-06-28 4 SANDELL SCOTT D See Note 2 GLUE Common Stock P - Purchase I 19,0000 1 050 000 19 950 7 692 298
2021-06-30 2021-06-28 4 SANDELL SCOTT D See Note 2 GLUE Common Stock C - Conversion I 669 002 6 642 298
2021-06-30 2021-06-28 4 SANDELL SCOTT D See Note 2 GLUE Common Stock C - Conversion I 3 257 328 5 973 296
2021-06-30 2021-06-28 4 SANDELL SCOTT D See Note 2 GLUE Common Stock C - Conversion I 2 715 968 2 715 968
2021-06-30 2021-06-28 4 Mathers Edward T See Note 2 GLUE Series C convertible preferred Stock C - Conversion I −2 361 912 0
2021-06-30 2021-06-28 4 Mathers Edward T See Note 2 GLUE Series B convertible preferred stock C - Conversion I −11 500 000 0
2021-06-30 2021-06-28 4 Mathers Edward T See Note 2 GLUE Series A-2 convertible preferred stock C - Conversion I −9 588 725 0
2021-06-30 2021-06-28 4 Mathers Edward T See Note 2 GLUE Common Stock P - Purchase I 19,0000 1 050 000 19 950 7 692 298
2021-06-30 2021-06-28 4 Mathers Edward T See Note 2 GLUE Common Stock C - Conversion I 669 002 6 642 298
2021-06-30 2021-06-28 4 Mathers Edward T See Note 2 GLUE Common Stock C - Conversion I 3 257 328 5 973 296
2021-06-30 2021-06-28 4 Mathers Edward T See Note 2 GLUE Common Stock C - Conversion I 2 715 968 2 715 968
2021-06-30 2021-06-28 4 MAKOWER JOSHUA See Note 2 GLUE Series C convertible preferred Stock C - Conversion I −2 361 912 0
2021-06-30 2021-06-28 4 MAKOWER JOSHUA See Note 2 GLUE Series B convertible preferred stock C - Conversion I −11 500 000 0
2021-06-30 2021-06-28 4 MAKOWER JOSHUA See Note 2 GLUE Series A-2 convertible preferred stock C - Conversion I −9 588 725 0
2021-06-30 2021-06-28 4 MAKOWER JOSHUA See Note 2 GLUE Common Stock P - Purchase I 19,0000 1 050 000 19 950 7 692 298
2021-06-30 2021-06-28 4 MAKOWER JOSHUA See Note 2 GLUE Common Stock C - Conversion I 669 002 6 642 298
2021-06-30 2021-06-28 4 MAKOWER JOSHUA See Note 2 GLUE Common Stock C - Conversion I 3 257 328 5 973 296
2021-06-30 2021-06-28 4 MAKOWER JOSHUA See Note 2 GLUE Common Stock C - Conversion I 2 715 968 2 715 968
2021-06-30 2021-06-28 4 Makhzoumi Mohamad See Note 2 GLUE Series C convertible preferred Stock C - Conversion I −2 361 912 0
2021-06-30 2021-06-28 4 Makhzoumi Mohamad See Note 2 GLUE Series B convertible preferred stock C - Conversion I −11 500 000 0
2021-06-30 2021-06-28 4 Makhzoumi Mohamad See Note 2 GLUE Series A-2 convertible preferred stock C - Conversion I −9 588 725 0
2021-06-30 2021-06-28 4 Makhzoumi Mohamad See Note 2 GLUE Common Stock P - Purchase I 19,0000 1 050 000 19 950 7 692 298
2021-06-30 2021-06-28 4 Makhzoumi Mohamad See Note 2 GLUE Common Stock C - Conversion I 669 002 6 642 298
2021-06-30 2021-06-28 4 Makhzoumi Mohamad See Note 2 GLUE Common Stock C - Conversion I 3 257 328 5 973 296
2021-06-30 2021-06-28 4 Makhzoumi Mohamad See Note 2 GLUE Common Stock C - Conversion I 2 715 968 2 715 968
2021-06-30 2021-06-28 4 Landsman Liza See Note 2 GLUE Series C convertible preferred Stock C - Conversion I −2 361 912 0
2021-06-30 2021-06-28 4 Landsman Liza See Note 2 GLUE Series B convertible preferred stock C - Conversion I −11 500 000 0
2021-06-30 2021-06-28 4 Landsman Liza See Note 2 GLUE Series A-2 convertible preferred stock C - Conversion I −9 588 725 0
2021-06-30 2021-06-28 4 Landsman Liza See Note 2 GLUE Common Stock P - Purchase I 19,0000 1 050 000 19 950 7 692 298
2021-06-30 2021-06-28 4 Landsman Liza See Note 2 GLUE Common Stock C - Conversion I 669 002 6 642 298
2021-06-30 2021-06-28 4 Landsman Liza See Note 2 GLUE Common Stock C - Conversion I 3 257 328 5 973 296
2021-06-30 2021-06-28 4 Landsman Liza See Note 2 GLUE Common Stock C - Conversion I 2 715 968 2 715 968
2021-06-30 2021-06-28 4 Chang Carmen See Note 2 GLUE Series C convertible preferred Stock C - Conversion I −2 361 912 0
2021-06-30 2021-06-28 4 Chang Carmen See Note 2 GLUE Series B convertible preferred stock C - Conversion I −11 500 000 0
2021-06-30 2021-06-28 4 Chang Carmen See Note 2 GLUE Series A-2 convertible preferred stock C - Conversion I −9 588 725 0
2021-06-30 2021-06-28 4 Chang Carmen See Note 2 GLUE Common Stock P - Purchase I 19,0000 1 050 000 19 950 7 692 298
2021-06-30 2021-06-28 4 Chang Carmen See Note 2 GLUE Common Stock C - Conversion I 669 002 6 642 298
2021-06-30 2021-06-28 4 Chang Carmen See Note 2 GLUE Common Stock C - Conversion I 3 257 328 5 973 296
2021-06-30 2021-06-28 4 Chang Carmen See Note 2 GLUE Common Stock C - Conversion I 2 715 968 2 715 968
2021-06-30 2021-06-28 4 Florence Anthony A. Jr. See Note 2 GLUE Series C convertible preferred Stock C - Conversion I −2 361 912 0
2021-06-30 2021-06-28 4 Florence Anthony A. Jr. See Note 2 GLUE Series B convertible preferred stock C - Conversion I −11 500 000 0
2021-06-30 2021-06-28 4 Florence Anthony A. Jr. See Note 2 GLUE Series A-2 convertible preferred stock C - Conversion I −9 588 725 0
2021-06-30 2021-06-28 4 Florence Anthony A. Jr. See Note 2 GLUE Common Stock P - Purchase I 19,0000 1 050 000 19 950 7 692 298
2021-06-30 2021-06-28 4 Florence Anthony A. Jr. See Note 2 GLUE Common Stock C - Conversion I 669 002 6 642 298
2021-06-30 2021-06-28 4 Florence Anthony A. Jr. See Note 2 GLUE Common Stock C - Conversion I 3 257 328 5 973 296
2021-06-30 2021-06-28 4 Florence Anthony A. Jr. See Note 2 GLUE Common Stock C - Conversion I 2 715 968 2 715 968
2021-06-30 2021-06-28 4 BASKETT FOREST See Note 2 GLUE Series C convertible preferred Stock C - Conversion I −2 361 912 0
2021-06-30 2021-06-28 4 BASKETT FOREST See Note 2 GLUE Series B convertible preferred stock C - Conversion I −11 500 000 0
2021-06-30 2021-06-28 4 BASKETT FOREST See Note 2 GLUE Series A-2 convertible preferred stock C - Conversion I −9 588 725 0
2021-06-30 2021-06-28 4 BASKETT FOREST See Note 2 GLUE Common Stock P - Purchase I 19,0000 1 050 000 19 950 7 692 298
2021-06-30 2021-06-28 4 BASKETT FOREST See Note 2 GLUE Common Stock C - Conversion I 669 002 6 642 298
2021-06-30 2021-06-28 4 BASKETT FOREST See Note 2 GLUE Common Stock C - Conversion I 3 257 328 5 973 296
2021-06-30 2021-06-28 4 BASKETT FOREST See Note 2 GLUE Common Stock C - Conversion I 2 715 968 2 715 968
2021-06-30 2021-06-28 4 Behbahani Ali See Note 2 GLUE Series C convertible preferred Stock C - Conversion I −2 361 912 0
2021-06-30 2021-06-28 4 Behbahani Ali See Note 2 GLUE Series B convertible preferred stock C - Conversion I −11 500 000 0
2021-06-30 2021-06-28 4 Behbahani Ali See Note 2 GLUE Series A-2 convertible preferred stock C - Conversion I −9 588 725 0
2021-06-30 2021-06-28 4 Behbahani Ali See Note 2 GLUE Common Stock P - Purchase I 19,0000 1 050 000 19 950 7 692 298
2021-06-30 2021-06-28 4 Behbahani Ali See Note 2 GLUE Common Stock C - Conversion I 669 002 6 642 298
2021-06-30 2021-06-28 4 Behbahani Ali See Note 2 GLUE Common Stock C - Conversion I 3 257 328 5 973 296
2021-06-30 2021-06-28 4 Behbahani Ali See Note 2 GLUE Common Stock C - Conversion I 2 715 968 2 715 968
2021-06-30 2021-06-28 4 New Enterprise Associates 17, L.P. GLUE Series C convertible preferred Stock C - Conversion D −2 361 912 0
2021-06-30 2021-06-28 4 New Enterprise Associates 17, L.P. GLUE Series B convertible preferred stock C - Conversion D −11 500 000 0
2021-06-30 2021-06-28 4 New Enterprise Associates 17, L.P. GLUE Series A-2 convertible preferred stock C - Conversion D −9 588 725 0
2021-06-30 2021-06-28 4 New Enterprise Associates 17, L.P. GLUE Common Stock P - Purchase D 19,0000 1 050 000 19 950 7 692 298
2021-06-30 2021-06-28 4 New Enterprise Associates 17, L.P. GLUE Common Stock C - Conversion D 669 002 6 642 298
2021-06-30 2021-06-28 4 New Enterprise Associates 17, L.P. GLUE Common Stock C - Conversion D 3 257 328 5 973 296
2021-06-30 2021-06-28 4 New Enterprise Associates 17, L.P. GLUE Common Stock C - Conversion D 2 715 968 2 715 968
2021-06-30 2021-06-28 4 Bolzon Bradley J PhD By Versant Vantage I, L.P. GLUE Series C convertible preferred stock C - Conversion I −2 699 328 0
2021-06-30 2021-06-28 4 Bolzon Bradley J PhD By Versant Vantage I, L.P. GLUE Series B convertible preferred stock C - Conversion I −4 150 000 0
2021-06-30 2021-06-28 4 Bolzon Bradley J PhD By Versant Capital VI, L.P. GLUE Series B convertible preferred stock C - Conversion I −3 000 000 0
2021-06-30 2021-06-28 4 Bolzon Bradley J PhD By Versant Capital VI, L.P. GLUE Series A convertible preferred stock C - Conversion I −20 004 280 0
2021-06-30 2021-06-28 4 Bolzon Bradley J PhD By Versant Vantage I, L.P. GLUE Common Stock P - Purchase I 19,0000 157 895 3 000 2 097 938
2021-06-30 2021-06-28 4 Bolzon Bradley J PhD By Versant Vantage I, L.P. GLUE Common Stock C - Conversion I 1 940 043 1 940 043
2021-06-30 2021-06-28 4 Bolzon Bradley J PhD By Versant Venture Capital VI, L.P. GLUE Common Stock C - Conversion I 6 515 869 6 799 115
2021-06-30 2021-06-28 4 Versant Venture Capital VI, L.P. By Versant Vantage I, L.P. GLUE Series C convertible preferred stock C - Conversion I −2 699 328 0
2021-06-30 2021-06-28 4 Versant Venture Capital VI, L.P. By Versant Vantage I, L.P. GLUE Series B convertible preferred stock C - Conversion I −4 150 000 0
2021-06-30 2021-06-28 4 Versant Venture Capital VI, L.P. GLUE Series B convertible preferred stock C - Conversion D −3 000 000 0
2021-06-30 2021-06-28 4 Versant Venture Capital VI, L.P. GLUE Series A convertible preferred stock C - Conversion D −20 004 280 0
2021-06-30 2021-06-28 4 Versant Venture Capital VI, L.P. By Versant Vantage I, L.P. GLUE Common Stock P - Purchase I 19,0000 157 895 3 000 2 097 938
2021-06-30 2021-06-28 4 Versant Venture Capital VI, L.P. By Versant Vantage I, L.P. GLUE Common Stock C - Conversion I 1 940 043 1 940 043
2021-06-30 2021-06-28 4 Versant Venture Capital VI, L.P. GLUE Common Stock C - Conversion D 6 515 869 6 799 115
2021-06-30 2021-06-28 4 Cormorant Asset Management, LLC See Footnotes GLUE Series C Convertible Preferred Stock C - Conversion I 477 857 0
2021-06-30 2021-06-28 4 Cormorant Asset Management, LLC See Footnotes GLUE Series B Convertible Preferred Stock C - Conversion I 2 124 343 0
2021-06-30 2021-06-28 4 Cormorant Asset Management, LLC See Footnotes GLUE Common Stock P - Purchase I 19,0000 600 000 11 400 3 202 200
2021-06-30 2021-06-28 4 Cormorant Asset Management, LLC See Footnotes GLUE Common Stock C - Conversion I 2 602 200 2 602 200
2021-06-25 2021-06-23 4 Behbahani Ali GLUE Stock Option (Right to Buy) A - Award D 19,00 47 132 47 132
2021-06-25 2021-06-23 4 Blackwell Kimberly GLUE Stock Option (Right to Buy) A - Award D 19,00 47 132 47 132
2021-06-25 2021-04-12 4 Blackwell Kimberly GLUE Stock Option (Right to Buy) A - Award D 6,14 7 081 7 081
2021-06-25 2021-06-23 4 Janku Filip GLUE Stock Option (Right to Buy) A - Award D 19,00 387 069 387 069
2021-06-25 2021-06-23 4 Mayweg Alexander GLUE Stock Option (Right to Buy) A - Award D 19,00 47 132 47 132
2021-06-25 2021-06-23 4 SCHIFF ANDREW N GLUE Stock Option (Right to Buy) A - Award D 19,00 47 132 47 132
2021-06-25 2021-06-23 4 Bolzon Bradley J PhD GLUE Stock Option (Right to Buy) A - Award D 19,00 47 132 47 132
2021-06-25 2021-03-11 4 Bolzon Bradley J PhD By Versant Vantage I, L.P. GLUE Series C convertible preferred stock A - Award I 2,9637 2 699 328 8 000 2 699 328
2021-06-25 2021-02-24 4 Bolzon Bradley J PhD By Versant Vantage I, L.P. GLUE Series B convertible preferred stock A - Award I 2,0000 2 075 000 4 150 4 150 000
2021-06-25 2021-02-24 4 Bolzon Bradley J PhD By Versant Capital VI, L.P. GLUE Series B convertible preferred stock A - Award I 2,0000 1 500 000 3 000 3 000 000
2021-06-25 2021-06-23 4 Warmuth Markus GLUE Stock Option (Right to Buy) A - Award D 19,00 141 623 141 623
2021-06-25 2021-04-12 4 Warmuth Markus GLUE Stock Option (Right to Buy) A - Award D 6,14 538 517 538 517
2021-06-25 2021-06-23 4 Wallace Owen B. GLUE Stock Option (Right to Buy) A - Award D 19,00 113 298 113 298
2021-06-25 2021-04-12 4 Wallace Owen B. GLUE Stock Option (Right to Buy) A - Award D 6,14 387 069 387 069
2021-06-25 2021-06-23 4 Siu Christine GLUE Stock Option (Right to Buy) A - Award D 19,00 47 132 47 132
2021-06-25 2021-04-12 4 Siu Christine GLUE Stock Option (Right to Buy) A - Award D 6,14 7 081 7 081
2021-06-25 2021-06-23 4 Leo Chandra P. GLUE Stock Option (Right to Buy) A - Award D 19,00 47 132 47 132
2021-06-25 2021-06-23 4 Tamboli Ajim GLUE Stock Option (Right to Buy) A - Award D 19,00 56 649 56 649
2021-06-25 2021-04-12 4 Tamboli Ajim GLUE Stock Option (Right to Buy) A - Award D 6,14 100 938 100 938
2021-06-23 3 Bolzon Bradley J PhD By Versant Venture Capital VI, L.P. GLUE Common Stock I 283 246
2021-06-23 3 Castle John C. GLUE Common Stock D 17 310
2021-06-23 3 Warmuth Markus GLUE Common Stock D 416 538
2021-06-23 3 Versant Vantage I GP-GP, LLC GLUE Common Stock D 283 246
P
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
S
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
A
Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)
C
Konvertering av derivat
D
Salg eller overføring av verdipapirer tilbake til selskapet
F
Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet
G
Gave av verdipapirer fra eller til insidere
K
Aksjebytting og lignende sikringsavtaler
M
Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)
V
En transaksjon frivilig rapportert på Skjema 4
J
Annet (med en fotnote som beskriver transaksjonen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista